During the past decade, 18-fluorodeoxyglucose (FDG) positron emission tomography (PET)
has rapidly evolved from a pure research modality to a clinical necessity. FDG-PET was …

Molecular imaging of tumor metabolism has gained considerable interest, since preclinical
studies have indicated a close relationship between the activation of various oncogenes and …

Positron emission tomography (PET) is now regularly used in the diagnosis and staging of
cancer. These uses and its ability to monitor treatment response would be aided by the …

The aim of this guideline is to provide general information about performing 18F-FDG PET or
PET/CT in inflammation and infection. We provide evidence for efficacy where it is available …

Sarcoidosis is a multi-system inflammatory disease characterized by the development of
inflammation and noncaseating granulomas that can involve nearly every organ system …

PURPOSE: To evaluate the standardized uptake value (SUV) of 2-[fluorine-18] fluoro-2-
deoxy-d-glucose (FDG) at positron emission tomography (PET) in the differentiation of …

Sarcoidosis is a granulomatous disease of which the etiology remains unknown. The
diverse clinical manifestations may challenge clinicians, particularly when conventional …

67Ga scintigraphy has been used for years in sarcoidosis for diagnosis and the extent of the
disease. However, little information is available on the comparison of 18F-FDG PET and …

Interpretation of studies from all imaging modalities requires a knowledge of the possible
pitfalls that may occur due to normal variation, artefacts and processes which may mimic …

Molecular imaging with positron emission tomography (PET) and single-photon emission
computed tomography (SPECT) is increasingly used to diagnose, characterize, and monitor …